home / stock / acet / acet short
Short Information | Adicet Bio Inc. (NASDAQ:ACET)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,393,633 |
Total Actual Volume | 35,588,014 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 169,682 |
Average Short Percentage | 11.20% |
Is there a ACET Short Squeeze or Breakout about to happen?
See the ACET Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-15-2024 | $1.41 | $1.4 | $1.53 | $1.38 | 2,664,779 | 233,149 | 8.75% |
05-14-2024 | $1.49 | $1.33 | $1.51 | $1.33 | 1,016,861 | 148,711 | 14.62% |
05-13-2024 | $1.5 | $1.44 | $1.555 | $1.43 | 877,563 | 77,337 | 8.81% |
05-10-2024 | $1.73 | $1.47 | $1.73 | $1.46 | 939,720 | 117,653 | 12.52% |
05-09-2024 | $1.66 | $1.63 | $1.7 | $1.62 | 440,942 | 53,028 | 12.03% |
05-08-2024 | $1.7 | $1.65 | $1.81 | $1.63 | 998,685 | 141,604 | 14.18% |
05-07-2024 | $1.67 | $1.73 | $1.865 | $1.66 | 1,612,871 | 179,937 | 11.16% |
05-06-2024 | $1.49 | $1.69 | $1.71 | $1.49 | 3,091,362 | 258,715 | 8.37% |
05-03-2024 | $1.45 | $1.45 | $1.56 | $1.4 | 4,866,272 | 281,872 | 5.79% |
05-02-2024 | $1.51 | $1.41 | $1.55 | $1.39 | 4,877,852 | 377,175 | 7.73% |
05-01-2024 | $1.55 | $1.52 | $1.63 | $1.51 | 3,886,748 | 256,436 | 6.6% |
04-30-2024 | $1.59 | $1.49 | $1.68 | $1.45 | 2,121,565 | 163,983 | 7.73% |
04-29-2024 | $1.7 | $1.59 | $1.765 | $1.59 | 1,605,582 | 127,336 | 7.93% |
04-26-2024 | $1.81 | $1.68 | $1.825 | $1.66 | 1,251,696 | 138,183 | 11.04% |
04-25-2024 | $1.89 | $1.81 | $1.95 | $1.8 | 851,580 | 120,309 | 14.13% |
04-24-2024 | $2.07 | $1.875 | $2.08 | $1.865 | 1,352,764 | 337,675 | 24.96% |
04-23-2024 | $2.14 | $2.1 | $2.25 | $2.07 | 1,147,946 | 159,032 | 13.85% |
04-22-2024 | $2 | $2 | $2.045 | $1.955 | 325,351 | 39,623 | 12.18% |
04-19-2024 | $2.01 | $1.95 | $2.035 | $1.9 | 727,751 | 68,641 | 9.43% |
04-18-2024 | $2.29 | $2.025 | $2.29 | $2.005 | 930,124 | 113,234 | 12.17% |
News, Short Squeeze, Breakout and More Instantly...
On track to initiate Phase 1 clinical trial evaluating ADI-001 in lupus nephritis in 2Q 2024 Presented promising preclinical data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting; on track to file investigational new drug (IND) in renal cell carcinoma in ...
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the acceptance of a poster presentation at the upcoming European Hematology Association (EHA) Hybrid Congr...
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the 2024 Ci...